Warning: The NCBI web site requires JavaScript to function. more...
Recent advances in biomedical applications of accelerator mass spectrometry.
Hah SS, Henderson PT, Turteltaub KW.
J Biomed Sci. 2009 Jun 17;16:54. Review. Erratum in: J Biomed Sci. 2009;16:111. Henderson, Paul T [added]; Turteltaub, Kenneth W [added].
Related citations
Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometry.
Lappin G, Garner RC.
Anal Bioanal Chem. 2004 Jan;378(2):356-64. Epub 2003 Nov 18.
Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom.
Barker J, Garner RC.
Rapid Commun Mass Spectrom. 1999;13(4):285-93. Review.
Applications of accelerator mass spectrometry for pharmacological and toxicological research.
Brown K, Tompkins EM, White IN.
Mass Spectrom Rev. 2006 Jan-Feb;25(1):127-45. Review.
Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics.
Lappin G, Stevens L.
Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1021-33. Review.
Accelerator mass spectrometry.
Hellborg R, Skog G.
Mass Spectrom Rev. 2008 Sep-Oct;27(5):398-427. Review.
Accelerator mass spectrometry of small biological samples.
Salehpour M, Forsgard N, Possnert G.
Rapid Commun Mass Spectrom. 2008 Dec;22(23):3928-34.
Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.
Dingley KH, Roberts ML, Velsko CA, Turteltaub KW.
Chem Res Toxicol. 1998 Oct;11(10):1217-22.
Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement.
Garner RC.
Curr Drug Metab. 2000 Sep;1(2):205-13. Review.
Accelerator mass spectrometry-enabled studies: current status and future prospects.
Arjomand A.
Bioanalysis. 2010 Mar;2(3):519-41. Review.
Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.
Turteltaub KW, Felton JS, Gledhill BL, Vogel JS, Southon JR, Caffee MW, Finkel RC, Nelson DE, Proctor ID, Davis JC.
Proc Natl Acad Sci U S A. 1990 Jul;87(14):5288-92.
Accelerator mass spectrometry for biomedical research.
Brown K, Dingley KH, Turteltaub KW.
Methods Enzymol. 2005;402:423-43. Review.
Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.
Nat Rev Drug Discov. 2003 Mar;2(3):233-40. Review.
Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction.
Turteltaub KW, Vogel JS, Frantz CE, Fultz E.
IARC Sci Publ. 1993;(124):293-301.
Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology.
White IN, Brown K.
Trends Pharmacol Sci. 2004 Aug;25(8):442-7. Review.
Quality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.
Kim SH, Kelly PB, Ortalan V, Browning ND, Clifford AJ.
Anal Chem. 2010 Mar 15;82(6):2243-52.
Neuroscience and accelerator mass spectrometry.
Palmblad M, Buchholz BA, Hillegonds DJ, Vogel JS.
J Mass Spectrom. 2005 Feb;40(2):154-9. Review.
Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data.
Bioanalysis. 2010 Mar;2(3):429-40. Review.
Comparison of a 250 kV single-stage accelerator mass spectrometer with a 5 MV tandem accelerator mass spectrometer--fitness for purpose in bioanalysis.
Young GC, Corless S, Felgate CC, Colthup PV.
Rapid Commun Mass Spectrom. 2008 Dec;22(24):4035-42.
Accelerator mass spectrometry analyses of environmental radionuclides: sensitivity, precision and standardisation
Hotchkis M, Fink D, Tuniz C, Vogt S.
Appl Radiat Isot. 2000 Jul;53(1-2):31-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on